中国医疗保险2024,Issue(2) :119-128.DOI:10.19546/j.issn.1674-3830.2024.2.015

基于医疗机构真实世界数据的丙型肝炎医保报销政策实施效果评估

Evaluation of the Implementation Effect of Hepatitis C Medical Insurance Reimbursement Policy Based on RWD of Medical Institutions

赵子淇 刘乙瑶 苟亮文 郭昭廷 冯海欢 胡明
中国医疗保险2024,Issue(2) :119-128.DOI:10.19546/j.issn.1674-3830.2024.2.015

基于医疗机构真实世界数据的丙型肝炎医保报销政策实施效果评估

Evaluation of the Implementation Effect of Hepatitis C Medical Insurance Reimbursement Policy Based on RWD of Medical Institutions

赵子淇 1刘乙瑶 2苟亮文 1郭昭廷 1冯海欢 3胡明1
扫码查看

作者信息

  • 1. 四川大学华西药学院 成都 610041
  • 2. 四川大学华西药学院 成都 610041;四川大学华西医院大数据中心 成都 610044
  • 3. 四川大学华西医院医保办 成都 610044
  • 折叠

摘要

目的:基于医疗机构真实世界数据,评估丙型肝炎医保报销政策实施效果,为丙型肝炎防治工作和医保政策提供参考和依据.方法:提取四川省成都市某三甲医院2014年1月至2020年12月的电子病历数据,采用间断时间序列分析等方法,从诊疗情况、医疗费用、药物使用和治疗效果等方面分析丙型肝炎患者诊疗行为和疾病负担的变化情况.结果:在诊疗情况方面,成都市门诊特病报销政策实施后就诊人次和治疗人次均出现瞬时增长,实行口服直接抗病毒药物(direct-acting antiviral agents,DAA)单行支付政策后诊疗情况无显著变化;在医疗费用方面,丙型肝炎患者的门诊疗程总费用、自付费用和药品费用均在单行支付政策实施后明显降低.结论:成都市丙型肝炎医保报销政策能够促进丙型肝炎患者积极就医,推动DAA方案的广泛使用,减轻患者负担,提高丙型肝炎的治疗效率.

Abstract

Objective:To evaluate the implementation effect of hepatitis C medical insurance reimbursement policy in Chengdu,and to provide reference and basis for hepatitis C prevention and treatment and medical insurance policy.Methods:The electronic medical record data of a three tertiary hospital in Chengdu from January 2014 to December 2020 were extracted,and the interrupted time series model was used to analyze the changes of diagnosis and treatment behavior and disease burden of hepatitis C patients from the aspects of diagnosis and treatment,medical expenses,drug use and treatment effect.Results:In terms of diagnosis and treatment,the number of visits and treatments increased instantaneously after the implementation of the outpatient reimbursement policy in Chengdu,and there was no significant change after the implementation of the single line payment policy for oral direct antiviral(DAA)drugs.In terms of medical expenses,the total cost of treatment,out of pocket expenses and drug expenses of hepatitis C patients have been significantly reduced after the implementation of the single line payment policy.Conclusion:Chengdu hepatitis C medical insurance reimbursement policy can promote hepatitis C patients to actively seek medical treatment,promote the widespread use of DAA scheme,reduce the burden of patients,and improve the treatment efficiency of hepatitis C.

关键词

丙型肝炎/政策绩效/报销政策/间断时间序列分析

Key words

hepatitis C/policy performance/reimbursement policy/interrupted time series

引用本文复制引用

基金项目

四川省科技厅重点研发项目(2021YFS0145)

出版年

2024
中国医疗保险
中国医疗保险研究会

中国医疗保险

影响因子:0.492
ISSN:1674-3830
参考文献量23
段落导航相关论文